EQT to buy SHL Medical stake

The GP will deploy from EQT VIII, which held a final close in February 2018 on €10.75bn. The fund was 66% deployed as of August 2019. The fund has so far made 10 platform investments, according to Unquote Data.

EQT declined to comment.

Company
Founded in 1989 by Roger Samuelsson and Martin Jelf, SHL manufactures drug delivery devices such as auto-injectors, pen injectors and inhaler systems. The group also manufactures pressure mattress systems, patient lifting slings, medical soft goods and laboratory equipment.

The company is based in Zug, Switzerland, and has operations in Sweden, Taiwan, the US and China. It employs 4,800 staff.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• DACH
• Healthcare
• Switzerland
• EQT